# Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries

> **NCT00310557** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 116 (actual)

## Conditions studied

- Renal Artery Stenosis

## Interventions

- **DRUG:** Gadopentetate dimeglumine (Magnevist)

## Key facts

- **NCT ID:** NCT00310557
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00310557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00310557, "Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00310557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*